Acceleron Pharma Inc is a company in the U.S. stock market and it is a holding in 50 U.S.-traded ETFs. XLRN has around 3.1M shares in the U.S. ETF market. The largest ETF holder of XLRN is the iShares NASDAQ Biotechnology ETF (IBB), with approximately 499.11K shares. Investors may also find of interest that the ETF with the largest allocation to XLRN stock is ALPS Medical Breakthroughs ETF (SBIO), with a portfolio weight of 4.24%. On average, U.S. ETFs allocate 0.44% of XLRN to their portfolios.
Additionally, XLRN is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with XLRN as a holding is the Invesco DWA Healthcare Momentum ETF (PTH), with a return of 26.78%.